Beta-Blockers in the Management of Hypertension and/or Chronic Kidney Disease (Q26825409)

main subject

arterial hypertension

1 reference

chronic renal insufficiency

inferred from title

1 reference

Hirofumi Tomiyama

1

1 reference

Akira Yamashina

series ordinal

2

1 reference

language of work or name

1 reference

2014

1 reference

International Journal of Hypertension

published in

1 reference

volume

2014

1 reference

page(s)

919256

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

start time

1 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Beta-blockers for hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Beta-blockers for hypertension

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Meta-analysis of the comparative effects of different classes of antihypertensive agents on brachial and central systolic blood pressure, and augmentation index

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Acute myocardial infarction and renal dysfunction: a high-risk combination

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

The role of sympathetic nervous system in the progression of chronic kidney disease in the era of catheter based sympathetic renal denervation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

The effect of antihypertensive drugs on chronic kidney disease: a comprehensive review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Sudden cardiac death in hemodialysis patients: an in-depth review

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

The role of Beta-blockers as first-line therapy in hypertension.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Non-invasive vascular function tests: their pathophysiological background and clinical application

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Do beta-blockers combined with RAS inhibitors make sense after all to protect against renal injury?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Atenolol in hypertension: is it a wise choice?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Differential effects of calcium antagonist subclasses on markers of nephropathy progression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Cardioprotection with beta-adrenoceptor blockers. Does lipophilicity matter?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

The second Lilly Prize Lecture, University of Newcastle, July 1977. beta-Adrenergic receptor blockade in hypertension, past, present and future

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

Effects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of stroke

28 September 2017

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Different drug classes have variable effects on blood pressure depending on the time of day.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Comparative efficacy of two different beta-blockers on 24-hour blood pressure control

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Left ventricular mass and mechanics in mild-to-moderate hypertension: effect of nebivolol versus telmisartan

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Effects of carvedilol versus metoprolol on endothelial function and oxidative stress in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Body weight changes with beta-blocker use: results from GEMINI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

β-blockers and the risk of incident depression in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Relation of beta-blocker-induced heart rate lowering and cardioprotection in hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Heart-rate profile during exercise as a predictor of sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Plasma norepinephrine predicts survival and incident cardiovascular events in patients with end-stage renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

beta-Blocker use in long-term dialysis patients: association with hospitalized heart failure and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

β-Blockers for prevention of sudden cardiac death in patients on hemodialysis: a propensity score analysis of the HEMO Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

A population-based analysis of the class effect of β-blockers after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Effect of nebivolol on parameters of cerebral haemodynamics and 24-hour blood pressure profile in patients with arterial hypertension

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3941231

28 November 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F919256

Synergistic relationship between changes in the pulse wave velocity and changes in the heart rate in middle-aged Japanese adults: a prospective study

21 January 2018

1 reference

12 December 2020

Should β blockers no longer be considered first-line therapy for the treatment of essential hypertension without comorbidities?

1 reference

12 December 2020

Treatment with carvedilol is associated with a significant reduction in microalbuminuria: a multicentre randomised study

1 reference

12 December 2020

Antihypertensive effects of beta-blockers administered once daily: 24-hour measurements

1 reference

12 December 2020

Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness

1 reference

12 December 2020

Metoprolol versus thiazide diuretics in hypertension. Morbidity results from the MAPHY Study

1 reference

12 December 2020

Risk/benefit assessment of beta-blockers and diuretics precludes their use for first-line therapy in hypertension

1 reference

12 December 2020

A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with

1 reference

12 December 2020

Beta-blocker prescription among Japanese cardiologists and its effect on various outcomes

1 reference

12 December 2020

Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. UK Prospective Diabetes Study Group

1 reference

12 December 2020

K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease

1 reference

12 December 2020

Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy

1 reference

12 December 2020

Identifiers

1 reference

1 reference

PubMed publication ID

24672712

1 reference